Skip to main content
Download PDF

Interventional pulmonary procedures and their outcomes in patients with STAT3 hyper IgE syndrome

BMC Surgery volume 23, Article number: 289 (2023) Cite this article

Abstract

Background

STAT3 hyperimmunoglobulin E syndrome (STAT3-HIES) also referred to as autosomal dominant HIES (AD-HIES) is an inborn error of immunity characterized by the classic triad of eczema, frequent opportunistic infections, and elevated serum IgE levels. As a consequence of lung sequels due to repeated infections and impaired tissue healing, patients may require interventional pulmonary procedures.

Method

Four patients with dominant-negative STAT3 mutations who had received interventional pulmonary procedures were enrolled. The demographic, clinical, and molecular characteristics were gathered through a medical record search. All reported STAT3-HIES patients in the literature requiring pulmonary procedures as part of their treatment were reviewed.

Result

Recurrent episodes of pneumonia and lung abscess were the most prevalent symptoms. The most common non-immunological features were scoliosis, failure to thrive, and dental problems such as primary teeth retention and disseminated decays. Bronchiectasis, lung abscess, pneumatocele, and cavitary lesion were the most prevalent finding on high-resolution computed tomography at the earliest recording. All patients underwent pulmonary surgery and two of them experienced complications.

Conclusion

Patients with STAT3-HIES have marked pulmonary infection susceptibility which may necessitate thoracic surgeries. Since surgical procedures involve a high risk of complication, surgical options are recommended to be utilized only in cases of drug resistance or emergencies.

Peer Review reports

Introduction

Hyper immunoglobulin E (IgE) syndrome (HIES) is an inborn error of immunity with an annual incidence of 1 in 100,000 people, which was initially described in 1966 [1, 2]. A high level of serum IgE is immunologic characteristic of several autosomal recessive IEIs, namely interleukin 6 (IL-6) receptor deficiency, IL-6 signal transducer deficiency, ZNF431 deficiency, DOCK8 deficiency, PGM3 deficiency, CARD11 deficiency, CARD14 deficiency, and Comel-Netherton syndrome [3, 4]. However, Job’s syndrome, the prototype of HIES (AD-HIES), arises from a dominant negative mutation of the STAT3 gene (signal transducer and activator of transcription 3) [5,6,7]. STAT3 is a member of the JAK-STAT pathway, which is involved in the differentiation and function of TH17. Abnormal Th17 function results in susceptibility to fungal and bacterial infections, particularly in the skin and respiratory system [8, 9]. Most patients present with the triad of eczema, frequent opportunistic infections, and elevated serum IgE levels. Moreover, non-immunological findings include facial characteristics, skeletal and dental abnormalities, vasculopathy, and malignancy [7,8,9]. Cutaneous involvement may present as skin abscesses and eczematous rashes. Abscesses commonly affect the face, neck, and scalp in the early years of life; they may not develop the typical signs and symptoms of infection and manifest as “cold “abscesses. The most prevalent pathogens are Staphylococcus aureus and Candida albicans. Papulopustular and eczematoid rashes first appear on the face and scalp in early infancy and progress to the upper trunk [10,11,12,13]. Sinopulmonary infections mostly caused by Staphylococcus aureus, Streptococcus, and Haemophilus species are prevalent and potentially fatal. Bronchitis and pneumatoceles are common complications of abnormal healing after lung infection which can be complicated due to secondary infection with Pseudomonas aeruginosa and Aspergillus fumigatus [1,2,3,4,5, 8, 14,15,16]. High levels of serum IgE (> 2,000 IU/uL) and eosinophilia are frequently observed in patients, however, increased serum IgE and eosinophilia do not predict the severity of the disease [1]. The IgE level tends to decrease or even reaches a normal level as age progresses. Low proportions of memory B and T cells associated with reduced IL-17A-producing T cells are also found in patients [1, 10].

General management goals in patients with STAT3-HIES include prophylaxis with antimicrobials, aggressive treatment of infection, and management of eczematoid dermatitis [17]. As a consequence of lung sequels due to repeated infections and impaired tissue healing, patients may require interventional pulmonary procedures such as abscesses drainage, lobectomy, or segmental lung resection because of the persistent pneumatoceles. Herein, we investigate the application of interventional pulmonary procedures and their outcomes in patients with hyper IgE syndrome.

Method

The study was performed at the National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Masih Daneshvari Hospital, Tehran, Iran, which is the national referral center for patients with inborn errors of immunity and pulmonary complications. The medical records of all patients with a clinical diagnosis of hyper IgE syndrome based on the European Society for Immunodeficiencies (ESID) diagnostic criteria and molecular diagnosis of dominant-negative STAT3 mutations were investigated for a history of interventional pulmonary procedures. Follow-up of alive patients was performed via telephone interviews with patients.

The immunologic profiles of patients were determined by the measurement of complete blood count (CBC), lymphocyte subsets, serum immunoglobulin levels (IgG, IgA, IgM, and IgE), human immunodeficiency virus (HIV) serology, and lymphocyte transformation test (LTT).

Based on the clinical and laboratory findings, an NIH score was determined for each patient according to the National Institutes of Health (NIH) HIES rating system [18].

The DNA samples were sent to the Laboratory of Human Genetics of Infectious Diseases, France, and Research Center for Immunodeficiencies, Iran, and genetic studies by whole-exome sequencing (WES) were performed to identify underlying genetic defects.

A questionnaire was prepared and filled with patients’ data including demographics, molecular and clinical features. All statistical analyses were performed using SPSS software (v. 26.0, Chicago, IL).

Written informed consent for participation in this study was obtained from patients or their parents. This study was performed in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of Shahid Beheshti University of Medical Sciences (Approval Code: IR.SBMU.NRITLD.REC.1400.049).

The literature search for reported STAT3-HIES patients with interventional pulmonary procedures was conducted in PubMed, Web of Science, and Scopus, applying the following keywords: “STAT3 Loss-of-Function Mutation”, “STAT3 Germ-Line Mutation signal transducer and activator of transcription 3 Loss-of-Function”, “dominant-negative STAT3”, “Mutations in STAT3”, “STAT3 deficiency”, “STAT3-LOF”, “Hyper-IgE syndrome”, “AD-HIES”, “Job's syndrome”, in combination with subsequent terminology: “surgery”, “intervention”, “drainage”, “thoracotomy”, “lobectomy”, “resection”, and “surgical treatment”. Reference lists of all full-text articles and major reviews were manually searched for additional studies.

Result

Summary of findings in study population

Four Iranian patients (3 males and 1 female) from four different families were enrolled, all of whom had a clinical and molecular diagnosis of dominant-negative STAT3 mutation and a history of interventional pulmonary surgery (Table 1). The NIH scores of all patients at the time of diagnosis exceeded 40. All patients except P4 had consanguineous parents and none of them had a family history of STAT3-HIES. The disease first manifested at a median (IQR) age of 0.1 (0.1–0.5) years, while the clinical diagnosis of HIES was confirmed at a median (IQR) age of 12.0 (8.0–17.0) years after a median (IQR) delay of 11.9 (16.5–7.9) years.

Table 1 Summary of studies reported STAT3-HIES patients with lung surgical interventions
Full size table

Recurrent episodes of pneumonia and lung abscess were the most prevalent symptoms (4/4). Three out of four patients (P1, P2, P4) developed pulmonary mold infection (Aspergillus was the most common organism). Moreover, non-pulmonary infections such as chronic diarrhea (P2, P3), otitis media, rhinosinusitis, conjunctivitis (P1), mucocutaneous candidiasis (P1, P3) and lymphadenitis (P1) were also detected. Skin infection, eczema and newborn rash were the most common skin manifestations presented in all patients. Food allergy was detected in 2 patients (P1, P3).

The most common non-immunological features were scoliosis (P2, P3, P4), failure to thrive (FTT) (P3, P4) and dental problems such as primary teeth retention (P2, P3) and disseminated decays (P2). Mandibular surgery due to a dental problem was performed in P2. Other non-immunological features contained clubbing, enteropathy, anemia (P2), oral ulcers (P3) and hyperextensible joints (P1).

Malignancy, chronic Epstein–Barr virus (EBV) infection and major bleeding or thrombotic vascular event were not found in any of the patients during the median (IQR) 4.75 (6.15–3.8) years of follow-up.

Immunological workup was performed in all 4 patients. The most prominent finding was the elevated serum IgE level and eosinophil count (4/4). White blood cell (WBC) count and lymphocyte subpopulations were normal in all patients except P3 who had increased CD19 + B cell count. High levels of IgG and IgM were detected in 3 patients (P1, P3, P4), while all had normal levels of IgA. The most prevalent findings on high-resolution computed tomography (HRCT) at the earliest recording were bronchiectasis (4/4), lung abscess (4/4), pneumatocele, and cavitary lesion (2/4). All patients underwent pulmonary surgery and P1 (bronchopleural fistula) and P3 (wound infection) experienced complications. Four patients received antibacterial and antifungal prophylaxis along with intravenous immunoglobulin (IVIG) (except P3). Two patients (P2 and P4) died due to pulmonary arrest and massive hemoptysis.

Detailed description of patients

Case 1

The patient was a 10-year-old male born to consanguineous parents with a history of eczematous dermatitis from the age of 10 days, which had extended to the face and diaper area. He had a productive cough and fever at the age of 3 years, which led to the diagnosis of pulmonary abscess and he underwent drainage and lower right lung lobectomy. He developed a cough and fever when he was 4 years old. Physical examination revealed hyperextensible joints. Laboratory findings at the age of 4 showed normal WBC count, increased eosinophil count (15%), IgE (532 (IU/ml)) and IgG level (2160 (IU/ml)). Lymphocyte subpopulations (CD3 + , CD4 + , CD8 + T cells, CD19 + B cell, natural killer (NK) cell) were normal. Bronchoalveolar lavage (BAL) culture was positive for Aspergillus terreus and Acinetobacter. Moreover, chest X-ray (CXR) demonstrated lung cavity formation in right lower lobe, pneumothorax, pleural effusion on the right side, and necrotizing pneumonia with empyema. According to the National Institutes of Health (NIH) HIES rating system [18], he scored 49 and the diagnosis of HIES was made. At the age of 5 years, he was presented with a fever and cough. The Chest sonography was suggesting for infectious lesion (abscess or empyema) and he underwent drainage and medical treatment. He was referred to the hospital again with cough and fever at the age of 7 years due to pulmonary empyema with Acinetobacter species. A thoracostomy window was opened for the patient from the back of the chest (Eloesser flapped surgery). Bronchopleural fistula occurred as a complication of surgery. He has received monthly IVIG and antimicrobial prophylaxis with tavanex, cephalexin and voriconazole. He responded well and the frequency of infections has reduced.

Case 2

The patient was a 26-year-old boy born to consanguineous parents. His family history was unremarkable. His medical history was notable for newborn rush, recurrent skin abscess, eczematous dermatitis, FTT, bronchiectasis and scoliosis. The HIES was suspected based on laboratory findings and clinical features. Laboratory findings at the age of 22 years revealed increased eosinophil count (610 × 103 (cells /µL)) and IgE level (> 1250 (IU/ml)). However, WBC count, lymphocyte subpopulations (CD3 + , CD4 + , CD8 + T cell, CD19 + B cell and NK cell) and serum level of immunoglobulins (IgG, IgA, IgM) were normal. Non-immunological findings included clubbing, chronic diarrhea, and anemia. According to the NIH HIES rating system, he scored 46. The diagnosis of HIES was confirmed by the identification of STAT3 missense mutation when he was 23 years old. Dental problems such as primary tooth retention, disseminated decay and abscess led to mandibular surgery. He developed pneumonia, hemoptysis, bronchiectasis, lung cavitary lesions and pneumatocele at the age of 24 years. In addition, Pseudomonas, Acinetobacter and pulmonary mold infection with Aspergillus were reported on BAL culture. CXR showed pneumatocele and HRCT revealed bronchiectasis, abscess and lung cavitary lesion. He underwent tube thoracostomy and thoracotomy due to permanent infection and empyema when he was 26 years. Although he received antimicrobial prophylaxis with vancomycin, tazocin, amikacin, tobramycin, colistin, meropenem, voriconazole and itraconazole, unfortunately, he died due to pulmonary arrest at the age of 26 years.

Case 3

The patient was a 23-year-old boy born to consanguineous parents. His family history was unremarkable. He had a history of newborn rash, eczematous dermatitis since 1-month-old, primary teeth retention, scoliosis, FTT, oral ulcer, food allergy and recurrent respiratory tract infections (pneumonia, croup, bronchiectasis). He was hospitalized due to croup at the age of 6 months and a skin abscess at the age of 13 years. Laboratory findings at the age of 12 years revealed normal WBC count, elevated eosinophil (1410 (cell/μL)) and CD 19 + B cell count (720 × 103 (cells /µL)) accompanied by high IgG (1758 mg/dl), IgE (800 IU/ml) and IgM (234 mg/dl) level. However, the IgA level and other lymphocyte subpopulations (CD3 + , CD4 + , CD8 + T cells, NK cell) were normal. DEXA scan showed normal bone densitometry and according to the NIH HIES rating system, he scored 47. Based on clinical features and laboratory findings the diagnosis of HIES was made at the age of 12 years old. At 18 years old he was referred to the hospital for fever and cough. CXR demonstrated cavitary lesion and pleural effusion. Moreover, HRCT findings revealed cavitary lesions, pleural effusion, pneumatocele, lung abscess and bronchiectasis. He underwent thoracotomy and decortication surgery due to pulmonary abscess and empyema which was further complicated by wound infection but responded to antibiotic therapy.

He received antimicrobial prophylaxis with vancomycin, imipenem, cotrimoxazole, and itraconazole and responded well.

Case 4

The patient was a 15-year-old girl born to non-consanguineous parents. Her family history was unremarkable. She had a history of newborn rash, eczematous dermatitis, skin abscess since she was 45 days old, scoliosis and FTT. In addition, multiple hospitalizations due to recurrent lung infections and lung abscesses were reported. At the age of 12, she was hospitalized due to pneumonia. Laboratory findings revealed increased eosinophil count (800 × 103 (cells /µL)), IgG (1805 mg/dl), IgM (199 mg/dl) and IgE level (4848 IU/ml). BAL culture was positive for Pseudomonas aeruginosa. Moreover, HRCT findings were suggestive of extensive cystic bronchiectasis, abscess and pneumatocele. CXR demonstrated multiple cavities. According to the NIH HIES rating system, she scored 55 and the diagnosis of HIES was confirmed based on clinical features, laboratory findings and identification of missense STAT3 mutation. She underwent a thoracotomy due to a lung abscess when she was 12 years old. She received pulmonary physiotherapy, IVIG and antimicrobial prophylaxis with colistin, vancomycin, meropenem, cotrimoxazole, fluconazole and amphotericin B, but unfortunately, she died due to massive hemoptysis at the age of 15 years.

Summary of the literature review

A total of 22 articles reported 77 cases of STAT3-HIES patients who received lung surgery for the management of pulmonary infections from 2010 to 2023 (Table 1). Gender was reported in 66 cases and included 35 male and 31 female. The median (IQR) age of patients at the time of first surgery was 9.5 (3.0–22.3) years. Lobectomy was the most frequent type of surgery performed in 45 patients (58.4%), followed by wedge resection (17, 22.1%), surgical drainage (12, 15.6%) and pneumonectomy (11, 14.3%). Six patients (7.8%) had thoracotomy. Other surgeries consisted of decortication (5, 6.5%), pleurectomy (4, 5.2%), thoracostomy (3, 3.9%), pleurodesis (3, 3.9%), window insertion (2, 2.6%), muscle flap repair and segmentectomy (1, 1.3%). For three patients the type of lung surgery was not specified (3.9%). Need for second surgery was reported in 21 patients (27.3%). Bronchopleural fistula was the most common complication after surgery (24, 31.2%). Seven patients experienced empyema (9.1%). Pneumonia and prolonged healing of wound were observed in 4 (5.2%) and 2 (2.6%) patients, respectively. Eight (10.8%) patients had deceased outcome.

Discussion

In this study, we presented four patients with STAT3-HIES receiving various types of interventional pulmonary procedures and searched the literature for similar patients. Recurrent pulmonary infections are frequently observed in STAT3-HIES patients since childhood. Surgical procedures are utilized to manage lung infections and complications such as the formation of pneumatoceles which are prone to secondary infection, abscess and empyema. The number of large cohorts evaluating the impact of interventional lung procedures in STAT3-HIES patients is limited, three of which is discussed in more details.

Post-operative sequels are often reported due to underlying dominant-negative STAT3 mutations and wound-healing abnormalities [15]. In the present study, bronchopleural fistula and wound infection occurred in two patients after surgery. In a retrospective study by Freeman et al. on 32 STAT3-HIES patients receiving 36 pulmonary surgeries, surgical complications were observed in more than half of all procedures. The most frequent complication, occurring in 47% of surgeries, was bronchopleural fistula which frequently led to empyema. Among complicated surgeries, 47% required further surgery due to long-standing bronchopleural fistula and empyema. It was suggested to prioritize medical treatment and only select surgical options in cases with ineffective medical treatment and significant symptoms [33].

In the same manner, in another study on nine patients with STAT3-HIES, Kroner et al. observed high rates of post-surgical complications, declined functional lung tissue, and negative impact on the long-term outcome. They recommended strict monitoring of pulmonary function and regular inhalation therapy with hypertonic saline, chest physiotherapy, airway clearance techniques, workout programs, and using intensive therapy for controlling infections (i.e., continuous use of oral antibiotics against S. aureus, regular antibiotic therapy in patients with high rates of pulmonary exacerbations, intense IV antibiotic therapy of exacerbations using fluoroquinolones) [15].

In the review of the literature, almost one-third of patients (27.3%) required more than one episode of lung surgery. The pre-surgery condition is an important determinant of surgical outcome. In accordance with previous studies, a history of infection with specific organisms was associated with a worse prognosis. Two out of four patients described in the current study suffered from Aspergillus infection and one of them required two other episodes of lung surgery. In a retrospective French study on STAT3-HIES patients with pulmonary Aspergillosis, six patients underwent seven episodes of surgery. The authors concluded that while many patients with HIES may develop aspergillosis infections, surgery can provide a permanent cure for pulmonary aspergillosis, but a recurrence might be inevitable [28].

None of the patients in the present study underwent hematopoietic stem cell transplantation (HSCT), although all patients received antimicrobial prophylaxis and IVIG and two of them responded well. Recently Harrison et al. in a cohort of patients with STAT3-HIES receiving HSCT suggested allogeneic HSCT as a curative measurement even in patients with prior severe lung disease. In their cohort, three patients had undergone lung surgeries before HSCT, but considerable improvement in lung disorders was only achieved after HSCT. None of them required lung surgery post-HSCT and no peri-transplant pulmonary inflammatory complications were observed [19].

This study faced several limitations including small number of participants and its retrospective nature. In addition, in the literature review some patients might have been included in more than one study, affecting the calculation of percentages. However, this study highlights the consequences of lung surgery in STAT3-HIES patients and the therapeutic dilemma for clinicians, which will be hopefully solved with future reports of more patients.

Conclusion

Patients with STAT3- HIES are prone to frequent pulmonary infection and other infection-related complications which lead to lung tissue destruction and significant mortality or morbidity; therefore, prompt diagnosis and prophylaxis initiation are critical. Furthermore, thoracic surgeries in these patients carry a considerable risk of complications, thus surgical procedures are only recommended when medical treatment has failed or there are severe symptoms.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Abbreviations

AD:

Autosomal dominant

AR:

Autosomal recessive

CBC:

Complete blood count

DEXA:

Dual-energy X-ray absorptiometry

EBV:

Epstein–Barr virus

GOF:

Gain of function

HIES:

Hyper immunoglobulin E syndrome

HRCT:

High-resolution computed tomography

HSCT:

Hematopoietic stem cell transplantation

IGRT:

Image-guided radiation therapy

NIH:

National Institutes of Health

WBC:

White blood cell

WES:

Whole-exome sequencing

References

  1. Bergerson JRE, Freeman AF. An Update on Syndromes with a Hyper-IgE Phenotype. Immunol Allergy Clin North Am. 2019;39(1):49–61.

    Article  PubMed  Google Scholar 

  2. Davis SD, Schaller J, Wedgwood RJ. Job’s syndrome. Recurrent, “cold”, staphylococcal abscesses. Lancet (London, England). 1966;1(7445):1013–5.

    Article  CAS  PubMed  Google Scholar 

  3. Tangye SG, Al-Herz W, Bousfiha A, Cunningham-Rundles C, Franco JL, Holland SM, et al. Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2022;42(7):1473–507.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Freeman AF, Milner JD. The Child with Elevated IgE and Infection Susceptibility. Curr Allergy Asthma Rep. 2020;20(11):65.

    Article  CAS  PubMed  Google Scholar 

  5. Minegishi Y, Saito M, Tsuchiya S, Tsuge I, Takada H, Hara T, et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature. 2007;448(7157):1058–62.

    Article  CAS  PubMed  Google Scholar 

  6. Holland SM, DeLeo FR, Elloumi HZ, Hsu AP, Uzel G, Brodsky N, et al. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med. 2007;357(16):1608–19.

    Article  CAS  PubMed  Google Scholar 

  7. Renner ED, Torgerson TR, Rylaarsdam S, Añover-Sombke S, Golob K, LaFlam T, et al. STAT3 mutation in the original patient with Job’s syndrome. N Engl J Med. 2007;357(16):1667–8.

    Article  CAS  PubMed  Google Scholar 

  8. Al-Shaikhly T, Ochs HD. Hyper IgE syndromes: clinical and molecular characteristics. Immunol Cell Biol. 2019;97(4):368–79.

    Article  CAS  PubMed  Google Scholar 

  9. Milner JD, Brenchley JM, Laurence A, Freeman AF, Hill BJ, Elias KM, et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature. 2008;452(7188):773–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Sowerwine KJ, Holland SM, Freeman AF. Hyper-IgE syndrome update. Ann N Y Acad Sci. 2012;1250:25–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Olaiwan A, Chandesris MO, Fraitag S, Lortholary O, Hermine O, Fischer A, et al. Cutaneous findings in sporadic and familial autosomal dominant hyper-IgE syndrome: a retrospective, single-center study of 21 patients diagnosed using molecular analysis. J Am Acad Dermatol. 2011;65(6):1167–72.

    Article  PubMed  Google Scholar 

  12. Langan RC, Sherry RM, Avital I, Heller T, Henderson C, Holland SM, et al. Safety of major abdominal surgical procedures in patients with hyperimmunoglobulinemia E (Job’s syndrome): a changing paradigm? J Gastrointest Surg. 2013;17(5):1009–14.

    Article  PubMed  Google Scholar 

  13. Tsilifis C, Freeman AF, Gennery AR. STAT3 Hyper-IgE Syndrome-an Update and Unanswered Questions. J Clin Immunol. 2021;41(5):864–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Gernez Y, Freeman AF, Holland SM, Garabedian E, Patel NC, Puck JM, et al. Autosomal Dominant Hyper-IgE Syndrome in the USIDNET Registry. J Allergy Clin Immunol Pract. 2018;6(3):996–1001.

    Article  PubMed  Google Scholar 

  15. Kröner C, Neumann J, Ley-Zaporozhan J, Hagl B, Meixner I, Spielberger BD, et al. Lung disease in STAT3 hyper-IgE syndrome requires intense therapy. Allergy. 2019;74(9):1691–702.

    Article  PubMed  Google Scholar 

  16. Freeman AF, Olivier KN. Hyper-IgE Syndromes and the Lung. Clin Chest Med. 2016;37(3):557–67.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Mogensen TH. STAT3 and the Hyper-IgE syndrome: Clinical presentation, genetic origin, pathogenesis, novel findings and remaining uncertainties. Jak-stat. 2013;2(2): e23435.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Grimbacher B, Schäffer AA, Holland SM, Davis J, Gallin JI, Malech HL, et al. Genetic linkage of hyper-IgE syndrome to chromosome 4. Am J Hum Genet. 1999;65(3):735–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Harrison SC, Tsilifis C, Slatter MA, Nademi Z, Worth A, Veys P, et al. Hematopoietic stem cell transplantation resolves the immune deficit associated with STAT3-dominant-negative hyper-IgE syndrome. J Clin Immunol. 2021;41(5):934–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Toribio-Dionicio C, Cubas-Guzmán D, Guerra-Canchari P, García-Sánchez V, Córdova-Calderón W. Pulmonary infections and surgical complications in a young girl with signal transducer and activator of transcription 3 loss-of-function mutation hyperimmunoglobulin E syndrome: a case report. Pediatr Allergy Immunol Pulmonol. 2021;34(1):33–7.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Frede N, Rojas-Restrepo J, de Oteyza ACG, Buchta M, Hübscher K, Gámez-Díaz L, et al. Genetic analysis of a cohort of 275 patients with hyper-IgE syndromes and/or chronic mucocutaneous candidiasis. J Clin Immunol. 2021;41(8):1804–38.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Adatia A, Allen CJ, Wald J, Richards CD, Waserman S, Nair P. Benralizumab for prednisone-dependent eosinophilic asthma associated with novel STAT3 loss of function mutation. Chest. 2021;159(4):e181–4.

    Article  CAS  PubMed  Google Scholar 

  23. Fang J, Yang Q, Pi B. Delayed diagnosis of hyperimmunoglobulin E syndrome with STAT3 mutation in mainland China: a case report and literature review. J Int Med Res. 2021;49(4):3000605211008073.

    Article  PubMed  Google Scholar 

  24. Gonzalez-Mancera MS, Johnson B, Mirsaeidi M. STAT3 gain-of-function mutation in a patient with pulmonary Mycobacterium abscessus infection. Respir Med Case Rep. 2020;30: 101125.

    PubMed  PubMed Central  Google Scholar 

  25. Kandilarova SM, Lesichkova SS, Gesheva NT, Yankova PS, Ivanov NH, Stoyanova GP, et al. On two cases with autosomal dominant hyper IgE syndrome: importance of immunological parameters for clinical course and follow-up. Case Reports Immunol. 2020;2020:6694957.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Zhang W, Ye J, Qiu C, Wang L, Jin W, Jiang C, et al. Rapid and precise diagnosis of T. marneffei pulmonary infection in a HIV-negative patient with autosomal-dominant STAT3 mutation: a case report. Ther Adv Respir Dis. 2020;14:1753466620929225.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Danion F, Duréault A, Gautier C, Senechal A, Persat F, Bougnoux ME, et al. Emergence of azole resistant-Aspergillus fumigatus infections during STAT3-deficiency. J Med Microbiol. 2020;69(6):844–9.

    Article  CAS  PubMed  Google Scholar 

  28. Duréault A, Tcherakian C, Poiree S, Catherinot E, Danion F, Jouvion G, et al. Spectrum of Pulmonary Aspergillosis in Hyper-IgE Syndrome with Autosomal-Dominant STAT3 Deficiency. J Allergy Clin Immunol Pract. 2019;7(6):1986-95.e3.

    Article  PubMed  Google Scholar 

  29. Fan H, Huang L, Yang D, Lin Y, Lu G, Xie Y, et al. Pediatric hyperimmunoglobulin E syndrome: a case series of 4 children in China. Medicine. 2018;97(14): e0215.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Ahmed S, Truong LD, Workeneh B. Fraternal twins with job’s syndrome and immune complex nephritis. CEN case reports. 2016;5(1):61–6.

    Article  PubMed  Google Scholar 

  31. Gernez Y, Tsuang A, Smith TD, Shahjehan K, Hui Y, Maglione PJ, et al. Hemoptysis in a patient with elevated immunoglobulin E. J Allergy Clin Immunol Pract. 2016;4(6):1054–8.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Zegarra-Linares R, Ang JY, Khan F, Asmar BI, McGrath EJ. A teenager patient with recurrent pulmonary abscesses. J Pediatr Infect Dis Soc. 2014;3(2):e20–3.

    Article  Google Scholar 

  33. Freeman AF, Renner ED, Henderson C, Langenbeck A, Olivier KN, Hsu AP, et al. Lung parenchyma surgery in autosomal dominant hyper-IgE syndrome. J Clin Immunol. 2013;33(5):896–902.

    Article  CAS  PubMed  Google Scholar 

  34. Zhang LY, Tian W, Shu L, Jiang LP, Zhan YZ, Liu W, et al. Clinical features, STAT3 gene mutations and Th17 cell analysis in nine children with hyper-IgE syndrome in mainland China. Scand J Immunol. 2013;78(3):258–65.

    Article  CAS  PubMed  Google Scholar 

  35. Sterbank J, Marino J, Jhaveri D, Horbal J, Tcheurekdjian H, Hostoffer R. A unique case of peroneus brevis/longus myositis in a patient with a STAT3 mutation. Ann Allergy Asthma Immunol. 2013;110(3):204–5.

    Article  PubMed  Google Scholar 

  36. Robinson WS, Arnold SR, Michael CF, Vickery JD, Schoumacher RA, Pivnick EK, et al. Case report of a young child with disseminated histoplasmosis and review of hyper immunoglobulin e syndrome (HIES). Clin Mol Allergy. 2011;9:14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Liu JY, Li Q, Chen TT, Guo X, Ge J, Yuan LX. Destructive pulmonary staphylococcal infection in a boy with hyper-IgE syndrome: a novel mutation in the signal transducer and activator of transcription 3 (STAT3) gene (p.Y657S). Eur J Pediatr. 2011;170(5):661–6.

    Article  PubMed  Google Scholar 

  38. Xie L, Hu X, Li Y, Zhang W, Chen L. Hyper-IgE syndrome with STAT3 mutation: a case report in Mainland China. Clin Dev Immunol. 2010;2010: 289873.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank the patients and their families for their contribution to this study.

Funding

The authors have received no funding for this study.

Author information

Authors and Affiliations

  1. Pediatric Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Seyed Alireza Mahdaviani, Mazdak Fallahi, Seyedeh Atefeh Hashemi-Moghaddam, Mahsa Rekabi, Zahra Daneshmandi & Mahnaz Jamee

  2. School of Medicine, Islamic Azad University of Medical Sciences, Tehran, Iran

    Soodeh Ghadimi

  3. Immunology and Allergy Department, Mofid Children’s Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Zahra Chavoshzadeh

  4. Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France

    Anne Puel

  5. Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran

    Nima Rezaei

  6. Lung Transplantation Research Center (LTRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Kambiz Sheikhy & Abolghasem Daneshvar Kakhki

  7. Tracheal Diseases Research Center (TDRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Seyed Reza Saghebi & Saviz Pejhan

  8. Pediatric Infections Research Center, Research Institute for Children’s Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Mahnaz Jamee

  9. Laboratory for Pediatric Immunology, Department of Pediatrics, Willem-Alexander Children’s Hospital, Leiden University Medical Center, Leiden, Netherlands

    Mahnaz Jamee

Authors
  1. Seyed Alireza Mahdaviani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Soodeh Ghadimi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mazdak Fallahi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Seyedeh Atefeh Hashemi-Moghaddam
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zahra Chavoshzadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Anne Puel
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Nima Rezaei
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Mahsa Rekabi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Zahra Daneshmandi
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Kambiz Sheikhy
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Abolghasem Daneshvar Kakhki
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Seyed Reza Saghebi
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Saviz Pejhan
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Mahnaz Jamee
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

SAM and MJ contributed to conceptualization, methodology, data curation, and supervision. SGH and MJ contributed to investigation and original draft preparation. AP and NR contributed to genetic analysis. MF, SAH contributed to data curation. ZCH, MR, ZD, KSH, ADK, SS, and SP contributed to reviewing and editing. All the authors approved the final version of the manuscript.

Corresponding authors

Correspondence to Soodeh Ghadimi or Mahnaz Jamee.

Ethics declarations

Ethics approval and consent to participate

This study was approved by the Ethics Committee of Shahid Beheshti University of Medical Sciences (Approval Code: IR.SBMU.NRITLD.REC.1400.049). This study was performed in accordance with the Declaration of Helsinki. Written informed consent for participation in this study was obtained from patients or their parents.

Consent for publication

Not applicable.

Competing interests

The authors have no conflicts of interest to declare that are relevant to the content of this article.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mahdaviani, S.A., Ghadimi, S., Fallahi, M. et al. Interventional pulmonary procedures and their outcomes in patients with STAT3 hyper IgE syndrome. BMC Surg 23, 289 (2023). https://0-doi-org.brum.beds.ac.uk/10.1186/s12893-023-02193-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://0-doi-org.brum.beds.ac.uk/10.1186/s12893-023-02193-2

Keywords

BMC Surgery

ISSN: 1471-2482

Contact us